NASDAQ:CBPO
Delisted
China Biologic Products Stock News
$119.99
+0 (+0%)
At Close: May 27, 2022
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
12:00am, Friday, 15'th Nov 2019Kite Lake Capital Management (UK) LLP Buys China Biologic Products Holdings Inc, Sells Tribune ...
12:00am, Thursday, 14'th Nov 2019China Biologic Reports Financial Results for the Third Quarter of 2019
09:30pm, Wednesday, 13'th Nov 2019
BEIJING, Nov. 13, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in C
China Biologic Products Q3 EPS $1.4 Beats $0.88 Estimate, Sales $136.1M Beat $127M Estimate
12:00am, Wednesday, 13'th Nov 2019AGF Investments America Inc. Buys Tetra Tech Inc, Ansys Inc, China Biologic Products Holdings ...
12:00am, Tuesday, 12'th Nov 2019China Biologic Products to Report Third Quarter 2019 Financial Results
01:30pm, Monday, 04'th Nov 2019
BEIJING , Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical ...
Did Hedge Funds Drop The Ball On China Biologic Products Holdings, Inc. (CBPO) ?
04:15pm, Thursday, 24'th Oct 2019
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
12:00pm, Thursday, 17'th Oct 2019
BEIJING, Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in Ch
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
12:00am, Thursday, 17'th Oct 2019China Biologic Forms Special Committee to Review "Going Private" Proposal
12:00pm, Tuesday, 24'th Sep 2019
BEIJING, Sept. 24, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in
China Biologic Forms Special Committee To Review Going Private Proposal
12:00am, Tuesday, 24'th Sep 2019Week In Review: Investor Group Bids $4.6 Billion To Acquire China Biologic
12:00am, Saturday, 21'st Sep 2019The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
11:46am, Friday, 20'th Sep 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 19.) 10X Genomics Inc (NASDAQ: TXG ) (listed
The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
12:00am, Friday, 20'th Sep 2019The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO
11:39am, Thursday, 19'th Sep 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 18) 10X Genomics Inc (NASDAQ: TXG ) (listed its share
